COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC

CONCLUSION: COPB2 is a novel prognostic biomarker and a promising therapeutic target for HCC.PMID:33824874 | PMC:PMC8007342 | DOI:10.1155/2021/6648078

Source: Biomed Res - April 7, 2021 Category: Research Authors: Jiayao Zhang Xiaoyu Wang Guangbing Li Jingyi He Ziwen Lu Yang Yang Yong Jiang Liyong Jiang Feiyu Li Jun Liu Source Type: research